307 related articles for article (PubMed ID: 22891333)
61. Somatic Mitochondrial DNA Mutations in Diffuse Large B-Cell Lymphoma.
Zeng AGX; Leung ACY; Brooks-Wilson AR
Sci Rep; 2018 Feb; 8(1):3623. PubMed ID: 29483551
[TBL] [Abstract][Full Text] [Related]
62. Somatic mitochondrial DNA mutations in oral cancer of betel quid chewers.
Tan DJ; Chang J; Chen WL; Agress LJ; Yeh KT; Wang B; Wong LJ
Ann N Y Acad Sci; 2004 Apr; 1011():310-6. PubMed ID: 15126307
[TBL] [Abstract][Full Text] [Related]
63. Somatic Mitochondrial Mutations in Oral Cavity Cancers among Senegalese Patients.
Toure S; Mbaye F; Gueye MD; Fall M; Dem A; Lamy JB; Sembene M
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2203-2208. PubMed ID: 31350985
[TBL] [Abstract][Full Text] [Related]
64. Identification of novel mitochondrial mutations in Leber's hereditary optic neuropathy.
Kumar M; Tanwar M; Saxena R; Sharma P; Dada R
Mol Vis; 2010 Apr; 16():782-92. PubMed ID: 20454697
[TBL] [Abstract][Full Text] [Related]
65. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.
Ju YS; Alexandrov LB; Gerstung M; Martincorena I; Nik-Zainal S; Ramakrishna M; Davies HR; Papaemmanuil E; Gundem G; Shlien A; Bolli N; Behjati S; Tarpey PS; Nangalia J; Massie CE; Butler AP; Teague JW; Vassiliou GS; Green AR; Du MQ; Unnikrishnan A; Pimanda JE; Teh BT; Munshi N; Greaves M; Vyas P; El-Naggar AK; Santarius T; Collins VP; Grundy R; Taylor JA; Hayes DN; Malkin D; ; ; ; Foster CS; Warren AY; Whitaker HC; Brewer D; Eeles R; Cooper C; Neal D; Visakorpi T; Isaacs WB; Bova GS; Flanagan AM; Futreal PA; Lynch AG; Chinnery PF; McDermott U; Stratton MR; Campbell PJ
Elife; 2014 Oct; 3():. PubMed ID: 25271376
[TBL] [Abstract][Full Text] [Related]
66. Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer.
Eoh KJ; Kim HM; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
BMC Cancer; 2020 Mar; 20(1):204. PubMed ID: 32164585
[TBL] [Abstract][Full Text] [Related]
67. Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors.
Iacobuzio-Donahue CA; Song J; Parmiagiani G; Yeo CJ; Hruban RH; Kern SE
Clin Cancer Res; 2004 Mar; 10(5):1597-604. PubMed ID: 15014009
[TBL] [Abstract][Full Text] [Related]
68. Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
Dougherty BA; Lai Z; Hodgson DR; Orr MCM; Hawryluk M; Sun J; Yelensky R; Spencer SK; Robertson JD; Ho TW; Fielding A; Ledermann JA; Barrett JC
Oncotarget; 2017 Jul; 8(27):43653-43661. PubMed ID: 28525389
[TBL] [Abstract][Full Text] [Related]
69. Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer.
Sui G; Zhou S; Wang J; Canto M; Lee EE; Eshleman JR; Montgomery EA; Sidransky D; Califano JA; Maitra A
Mol Cancer; 2006 Dec; 5():73. PubMed ID: 17166268
[TBL] [Abstract][Full Text] [Related]
70. Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy.
Kumar M; Kaur P; Kumar M; Saxena R; Sharma P; Dada R
Mol Vis; 2012; 18():2687-99. PubMed ID: 23170061
[TBL] [Abstract][Full Text] [Related]
71. Analysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.
Kim YM; Lee SW; Chun SM; Kim DY; Kim JH; Kim KR; Kim YT; Nam JH; van Hummelen P; MacConaill LE; Hahn WC; Jang SJ
PLoS One; 2014; 9(6):e99451. PubMed ID: 24936796
[TBL] [Abstract][Full Text] [Related]
72. Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas.
Mithani SK; Smith IM; Topalian SL; Califano JA
Melanoma Res; 2008 Jun; 18(3):214-9. PubMed ID: 18477896
[TBL] [Abstract][Full Text] [Related]
73. Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma.
Choi MC; Hwang S; Kim S; Jung SG; Park H; Joo WD; Song SH; Lee C; Kim TH; Kang H; An HJ
Cancer Res Treat; 2020 Apr; 52(2):634-644. PubMed ID: 32019284
[TBL] [Abstract][Full Text] [Related]
74. Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Menor M; Zhu Y; Wang Y; Zhang J; Jiang B; Deng Y
BMC Med Genomics; 2019 Jan; 12(Suppl 1):24. PubMed ID: 30704450
[TBL] [Abstract][Full Text] [Related]
75. Detection of somatic mutations and germline polymorphisms in mitochondrial DNA of uterine fibroids patients.
Shaik NA; Lone WG; Khan IA; Vaidya S; Rao KP; Kodati VL; Hasan Q
Genet Test Mol Biomarkers; 2011; 15(7-8):537-41. PubMed ID: 21453057
[TBL] [Abstract][Full Text] [Related]
76. Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling.
Choi YJ; Rhee JK; Hur SY; Kim MS; Lee SH; Chung YJ; Kim TM; Lee SH
J Pathol; 2017 Jan; 241(1):57-66. PubMed ID: 27741368
[TBL] [Abstract][Full Text] [Related]
77. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer.
Wu CW; Yin PH; Hung WY; Li AF; Li SH; Chi CW; Wei YH; Lee HC
Genes Chromosomes Cancer; 2005 Sep; 44(1):19-28. PubMed ID: 15892105
[TBL] [Abstract][Full Text] [Related]
78. Somatic mitochondrial DNA mutations in different grades of glioma.
Soon BH; Abu N; Abdul Murad NA; Then SM; Abu Bakar A; Fadzil F; Thanabalan J; Mohd Haspani MS; Toh CJ; Kumar R; Jaafar AS; Mohd Azli AN; Mohd Azahar MS; Paramasvaran S; Palaniandy K; Mohd Tamil A; Jamal R
Per Med; 2022 Jan; 19(1):25-39. PubMed ID: 34873928
[No Abstract] [Full Text] [Related]
79. Clinical value of mitochondrial mutations in colorectal cancer.
Lièvre A; Chapusot C; Bouvier AM; Zinzindohoué F; Piard F; Roignot P; Arnould L; Beaune P; Faivre J; Laurent-Puig P
J Clin Oncol; 2005 May; 23(15):3517-25. PubMed ID: 15908662
[TBL] [Abstract][Full Text] [Related]
80. Identifying Somatic Mitochondrial DNA Mutations.
An J; Min KI; Ju YS
Methods Mol Biol; 2022; 2493():153-165. PubMed ID: 35751814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
